Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Wei, Yao ^a   Niu, Ben ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; ONCOPROTEIN; UNCLASSIFIED DRUG; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN;

CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FOLLOW UP; GENE EXPRESSION; GLIOMA; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; CASE CONTROL STUDY; GENETICS; META ANALYSIS; METABOLISM; NEOPLASM; PATHOLOGY;

CASE-CONTROL STUDIES; HUMANS; NEOPLASMS; RNA, LONG NONCODING;

EID: 84941702751     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/164635     Document Type: Review

References (29)

1. R. Spizzo, M. I. Almeida, A. Colombatti, andG. A. Calin, "Long non-coding RNAs and cancer: a new frontier of translational research," Oncogene, vol. 31, no. 43, pp. 4577-4587, 2012.
2. K. C. Wang and H. Y. Chang, "Molecular mechanisms of long noncoding RNAs," Molecular Cell, vol. 43, no. 6, pp. 904-914, 2011.
3. I. Berindan-Neagoe, P. D. C. Monroig, B. Pasculli, and G. A. Calin, "MicroRNAome genome: a treasure for cancer diagnosis and therapy," CA: Cancer Journal for Clinicians, vol. 64, no. 5, pp. 311-336, 2014.
4. J. E. Wilusz, H. Sunwoo, and D. L. Spector, "Long noncoding RNAs: functional surprises from the RNA world," Genes and Development, vol. 23, no. 13, pp. 1494-1504, 2009.
5. T.Gutschner and S.Diederichs, "The hallmarks of cancer: a long non-coding RNA point of view," RNA Biology, vol. 9, no. 6, pp. 703-709, 2012.
6. P. Ji, S. Diederichs,W.Wang et al., "MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer," Oncogene, vol. 22, no. 39, pp. 8031-8041, 2003.
7. L. H. Schmidt, T. Spieker, S. Koschmieder et al., "The long noncoding MALAT-1 RNA indicates a poor prognosis in nonsmall cell lung cancer and induces migration and tumor growth," Journal of Thoracic Oncology, vol. 6, no. 12, pp. 1984-1992, 2011.
8. L. Shen, L. Chen, Y. Wang, X. Jiang, H. Xia, and Z. Zhuang, "Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer," Journal of Neuro-Oncology, vol. 121, no. 1, pp. 101-108, 2014.
9. M.-C. Lai, Z. Yang, L. Zhou et al., "Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation," Medical Oncology, vol. 29, no. 3, pp. 1810-1816, 2012.
10. H.-M. Zhang, F.-Q. Yang, S.-J. Chen, J. Che, and J.-H. Zheng, "Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma," Tumor Biology, vol. 36, no. 4, pp. 2947-2955, 2014.
11. H.-T. Zheng, D.-B. Shi, Y.-W. Wang et al., "High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer," International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 3174-3181, 2014.
12. Y. Okugawa, Y. Toiyama, K. Hur et al., "Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis," Carcinogenesis, vol. 35, no. 12, pp. 2731-2739, 2014.
13. M. J. Ellis, L. Ding, D. Shen et al., "Whole-genome analysis informs breast cancer response to aromatase inhibition," Nature, vol. 486, no. 7403, pp. 353-360, 2012.
14. F. Guo, Y. Li, Y. Liu, J. Wang, Y. Li, and G. Li, "Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion," Acta Biochimica et Biophysica Sinica, vol. 42, no. 3, pp. 224-229, 2010.
15. E.-J. Pang, R. Yang, X.-B. Fu, and Y.-F. Liu, "Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer," Tumor Biology, vol. 36, no. 4, pp. 2403-2407, 2015.
16. L. Ying, Q. Chen, Y. Wang, Z. Zhou, Y. Huang, and F. Qiu, "Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition," Molecular BioSystems, vol. 8, no. 9, pp. 2289-2294, 2012.
17. K. Yamada, J. Kano, H. Tsunoda et al., "Phenotypic characterization of endometrial stromal sarcoma of the uterus," Cancer Science, vol. 97, no. 2, pp. 106-112, 2006.
18. K.-X. Ma, H.-J. Wang, X.-R. Li et al., "Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma," Tumor Biology, 2015.
19. J. Fellenberg, L. Bernd, G. Delling, D. Witte, and A. Zahlten-Hinguranage, "Prognostic significance of drug-regulated genes in high-grade osteosarcoma," Modern Pathology, vol. 20, no. 10, pp. 1085-1094, 2007.
20. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, "Practical methods for incorporating summary time-toevent data into meta-analysis," Trials, vol. 8, article 16, 2007.
21. J. A. Hayden, P. Côté, and C. Bombardier, "Evaluation of the quality of prognosis studies in systematic reviews," Annals of Internal Medicine, vol. 144, no. 6, pp. 427-437, 2006.
22. V. Tripathi, J. D. Ellis, Z. Shen et al., "The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation,"Molecular Cell, vol. 39, no. 6, pp. 925-938, 2010.
23. V. Tripathi, Z. Shen, A. Chakraborty et al., "Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB," PLoS Genetics, vol. 9, no. 3,Article ID e1003368, 2013.
24. T. Gutschner, M. Hämmerle, M. Eißmann et al., "The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells," Cancer Research, vol. 73, no. 3, pp. 1180-1189, 2013.
25. B. Zhang, G. Arun, Y. S. Mao et al., "The lncRNA malat1 is dispensable formouse development but its transcription plays a cis-regulatory role in the adult," Cell Reports, vol. 2, no. 1, pp. 111-123, 2012.
26. R. Miyagawa, K. Tano, R. I. E. Mizuno et al., "Identification of cis-and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles," RNA, vol. 18, no. 4, pp. 738-751, 2012.
27. L. Yang, C. Lin, W. Liu et al., "ncRNA-and Pc2 methylationdependent gene relocation between nuclear structuresmediates gene activation programs," Cell, vol. 147, no. 4, pp. 773-788, 2011.
28. K. M. Michalik, X. You, Y. Manavski et al., "Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth," Circulation Research, vol. 114, no. 9,pp. 1389-1397, 2014.
29. J.-H. Liu, G. Chen, Y.-W. Dang, C.-J. Li, and D.-Z. Luo, "Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 7, pp. 2971-2977, 2014.